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Chondrosarcoma of the skull is a rare primary malignant
tumor that is slow-growing, but locally aggressive. A 5-
year-old, golden retriever was presented to our hospital
with a swelling in the left side of her head, and the
swelling had slowly enlarged over the previous month.
There were no significant changes on the neurological
examination. A computed tomography scan revealed a
large mass involving bone destruction and prominent
matrix mineralization. T1-weighted magnetic resonance
imaging showed a slightly low-signal intensity area and a
T2-weighted image revealed marked, high-signal intensity.
There was compression of the adjacent brain parenchyma.
Histopathological examination confirmed the lesion to be
a chondrosarcoma.
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Chondrosarcoma is the second most common primary
tumor of the bone in both humans and dogs, and it accounts
for approximately 5% to 10% of all canine primary bone
tumors [9]. Primary chondrosarcomas in dogs have reportedly
been found in the appendicular skeleton, mammary gland,
digit, tongue, kidney, abdominal wall, omentum, trachea,
synovium, subcutaneous tissue, larynx, lung, pericardium,
right atrium, mitral valve, aorta and penile urethra [2,8,9].
However, chondrosarcoma on the skull is rare, representing
approximately 0.1% of all head and neck neoplasms in
humans [3]. This report describes the clinical presentation
and diagnostic investigation, which involved x-ray, computed
tomography (CT, Pratico; Hitachi Medico, Japan), and
magnetic resonance imaging (MRI, Aperto Inspire; Hitachi
Medico, Japan) examinations, of a dog with chondrosarcoma in
its skull.
A 5-year-old, neutered, female golden retriever was
presented to the Yamaguchi University Veterinary Medical
Hospital with a mass on the head. The owner reported that
the mass was found one month previously and it had slowly
enlarged. However, the dog appeared otherwise well, and it
had no past trauma or medical history except for otitis
externa. A physical examination revealed a hard mass,
which was fixed to the left caudal part of the head, and the
skin overlying the lesion was normal. There were no
significant abnormalities on the neurological and blood
examinations. Radiographic examination of the head revealed
a lytic lesion with endosteal scalloping on the parietal bone
that extended to the occipital bone (Fig. 1A) and there was
faint calcific opacity in the overlying mass (Fig. 1B). A CT
scan (Fig. 2) revealed a large mass involving bone destruction,
prominent matrix mineralization and low-attenuation areas.
Transverse T1-weighted MRI (Fig. 3A) showed a slightly
low-signal intensity area on the brain and adjacent lesion,
and the same area showed high-signal intensity on the T2-
weighted images (Fig. 3B & D). The adjacent brain
parenchyma was compressed by the mass (Fig. 3D). The
mass had mild marginal enhancement on a contrast-
enhanced T1-weighted image, and it was separated from the
brain parenchyma (Fig. 3C). Biopsy of the lesion was
performed, and the mass was histopathologically diagnosed
as chondrosarcoma (Fig. 4). The owner was unwilling to
permit palliative surgery.
Chondrosarcoma is a malignant tumor involving the cells
that produce a cartilage matrix [7]. Although chondrosarcomas
most commonly arise from either the cartilaginous
structures or the bones derived from chondroid precursors,
chondrosarcomas may also arise in those areas where
cartilage is not normally found. The chondrosarcomas
developing in soft tissue presumably arise from cartilaginous
differentiation of primitive mesenchymal cells [3].
In a retrospective study of 97 dogs with chondrosarcomas
[8], those dogs with a mean age of 8.7 years (range: 1 to 15
years) and medium-to-large breed dogs (mean weight: 28
kg) were most commonly affected. Golden retrievers had a
3.12 times greater risk of developing chondrosarcoma than
any other breed. The nasal cavity was the most common site
(28.8%), followed by the ribs (17.5%), appendicular
skeleton (17.5%), extraskeletal sites (13%), and facial bones
(9%). Chondrosarcomas of the facial bones were located in
the mandibule, maxilla and orbit [8]. Human chondrosarcoma
commonly arises in the appendicular skeleton and ribs. The
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most common sites in the head and neck have been variably
reported as the jaw bones, paranasal sinuses, nasal cavity,
the maxilla and cervical vertebrae [3]. There are fewer
reports of chondrosarcomas on the head, including the
cranium, in comparison with other lesions, in both human
and veterinary medicine [3-5,8].
Multilobular osteochondrosarcoma (MLO) is an uncommon
tumor that generally arises in the skull of dogs [5,9]. MLO
has similar radiographic characteristics and MRI appearance
as chondrosarcomas have and it histologically contains a
chondroid and osteoid matrix. On the histopathological
examination of this case, a chondroid matrix was dominant,
and this led to the diagnosis of chondrosarcoma. However,
MLO could not be ruled out because the histopathological
samples were only collected at several points via needle
punch biopsy.
The radiographic (Fig. 1) and CT (Fig. 2) examinations
showed soft tissue calcification and bone lysis with
endosteal scalloping. On MRI examination (Fig. 3), a T1-
weighted image showed a low-signal intensity area on the
brain and adjacent muscle, and a T2-weighted image
revealed marked high-signal intensity, which was similar to
that of cerebrospinal fluid. Hyaline cartilage neoplasms
typically grow with a lobular architecture. This growth
pattern frequently causes lobular, deep, endosteal scalloping
that may result in focal areas of cortical penetration and
associated extension into the soft-tissue. Non-mineralized
regions have a translucent appearance, reflecting the high
water content of hyaline cartilage, and particularly in low-
grade lesions. The lobular architecture typical of all hyaline
cartilage neoplasms, in most cases, can best be seen at the
lesion margin. The non-mineralized components of
chondrosarcoma have high-signal intensity on T2-weighted
MRI, which is again a reflection of the high water content of
hyaline cartilage [7,10].
The dog had a mass on the head that had invaded the
parietal and occipital bones, and this compressed the right
occipital lobe of the cerebrum and the cerebellum. However,
the mass was round and well defined from the brain
Fig. 1. Radiograph of the head revealed lytic lesion with
endosteal scalloping (A, arrow) and calcification within the sof t
tissue (B, arrow).
Fig. 2. CT scan showed bone destruction of the skull (A) and
matrix calcification (A, B).
Fig. 3. Transverse T1-weighted MRI (A) and its contrast-
enhanced image (C) showed a slightly low-signal intensity are a
and mild marginal enhancement around the mass, respectively.
T2-weighted image revealed the marked high-signal intensity (B,
D) and some compression of the adjacent brain parenchyma (D).
Fig. 4. Histopathological finding revealed proliferation of the
atypical chondrocytes (arrows) and cartilaginous component (C).
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parenchyma. Despite the large intracranial mass lesion, the
dog did not show any neurological disorders and the owner
did not notice any changes in its daily routine. The most
frequently reported clinical sign in dogs with chondrosarcoma
involving the facial bones (included all the bones of the
skull not associated with the nasal cavity or paranasal
sinuses) is a mass or swelling over the affected area
[3,5,8,9]. Canine chondrosarcomas tend to grow slowly and
they have limited metastatic potential, with the reported
metastatic rates ranging from 0 to 20.5% [2]. Because of its
slow growth, the brain parenchyma may become accustomed
to the compression caused by the mass.
In this case, the owner was unwilling to have palliative
surgery performed. The location of tumor and the histologic
grade are generally prognostically related and surgical
excision is the primary treatment [3,8]. There was a
significant difference in survival time between the dogs with
appendicular chondrosarcoma that were treated with
amputation and those dogs treated by local excision [8].
Investigators have identified that chondrosarcoma is not a
radio-responsive tumor and as a result, radiotherapy is not
useful as a primary modality or as an adjunct to surgery [3].
The median survival times of dogs suffering with nasal
chondrosarcoma and treated with rhinotomy did not differ
significantly from those dogs for which rhinotomy was
followed by radiotherapy [8].
Since the expansion of MRI and CT into the veterinary
field, the management of tumors has been a formidable
challenge for clinicians. However, many patients with extensive
disease, and especially those displaying slow progression of
tumors, show clinical signs only in the late stages of the
disease when gross total resection of the tumor tissues is
difficult at best. Because the skull is a complex structure
with many overlapping shadows, it may be difficult to
discern the pattern of bone destruction and the presence of
matrix by using only X-ray. It is recommended that CT and
MRI be performed when a lesion is suspected or discovered
on the head, even where there are no signs of neurological
disorder. Both CT and MRI may be necessary for thoroughly
evaluating the extent of tumor [1,4,6].
In this case, CT was useful for detecting the matrix
mineralization, and T2-weighted MRI allowed visualization
of the nonmineralized components of chondrosarcoma that
had a high-signal intensity, which reflected the high water
content of hyaline cartilage.
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